ZA200501839B - Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor - Google Patents
Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumorInfo
- Publication number
- ZA200501839B ZA200501839B ZA200501839A ZA200501839A ZA200501839B ZA 200501839 B ZA200501839 B ZA 200501839B ZA 200501839 A ZA200501839 A ZA 200501839A ZA 200501839 A ZA200501839 A ZA 200501839A ZA 200501839 B ZA200501839 B ZA 200501839B
- Authority
- ZA
- South Africa
- Prior art keywords
- achaete
- scute
- polypeptides
- tumor
- diagnosis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40708702P | 2002-08-29 | 2002-08-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200501839B true ZA200501839B (en) | 2006-10-25 |
Family
ID=31978417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200501839A ZA200501839B (en) | 2002-08-29 | 2003-06-04 | Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor |
Country Status (9)
Country | Link |
---|---|
US (2) | US20050260634A1 (es) |
EP (1) | EP1575515A4 (es) |
JP (1) | JP2006512901A (es) |
KR (1) | KR20050057047A (es) |
AU (1) | AU2003243398A1 (es) |
CA (1) | CA2496925A1 (es) |
MX (1) | MXPA05002287A (es) |
WO (1) | WO2004019857A2 (es) |
ZA (1) | ZA200501839B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090085697A (ko) | 2000-02-23 | 2009-08-07 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 종양 특이적 동물 단백질 |
US7811574B2 (en) | 2000-02-23 | 2010-10-12 | Glaxosmithkline Biologicals S.A. | Tumour-specific animal proteins |
CA2496925A1 (en) * | 2002-08-29 | 2004-03-11 | Genentech, Inc. | Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor |
NZ596501A (en) | 2009-05-27 | 2013-11-29 | Glaxosmithkline Biolog Sa | Casb7439 constructs |
US10260089B2 (en) | 2012-10-29 | 2019-04-16 | The Research Foundation Of The State University Of New York | Compositions and methods for recognition of RNA using triple helical peptide nucleic acids |
CN116756272B (zh) * | 2023-06-20 | 2024-02-23 | 广州大学 | 面向中文威胁报告的att&ck模型映射方法及装置 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4708871A (en) * | 1983-03-08 | 1987-11-24 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
NZ215865A (en) * | 1985-04-22 | 1988-10-28 | Commw Serum Lab Commission | Method of determining the active site of a receptor-binding analogue |
US5571689A (en) * | 1988-06-16 | 1996-11-05 | Washington University | Method of N-acylating peptide and proteins with diheteroatom substituted analogs of myristic acid |
US5663143A (en) * | 1988-09-02 | 1997-09-02 | Dyax Corp. | Engineered human-derived kunitz domains that inhibit human neutrophil elastase |
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5208020A (en) * | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
CA2090860C (en) * | 1990-11-21 | 2003-09-16 | Richard A. Houghten | Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures |
DK0564531T3 (da) * | 1990-12-03 | 1998-09-28 | Genentech Inc | Berigelsesfremgangsmåde for variantproteiner med ændrede bindingsegenskaber |
US5641870A (en) * | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
US7442776B2 (en) * | 1999-10-08 | 2008-10-28 | Young David S F | Cancerous disease modifying antibodies |
KR20090085697A (ko) * | 2000-02-23 | 2009-08-07 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 종양 특이적 동물 단백질 |
CA2496925A1 (en) * | 2002-08-29 | 2004-03-11 | Genentech, Inc. | Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor |
-
2003
- 2003-06-04 CA CA002496925A patent/CA2496925A1/en not_active Abandoned
- 2003-06-04 EP EP03791556A patent/EP1575515A4/en not_active Withdrawn
- 2003-06-04 AU AU2003243398A patent/AU2003243398A1/en not_active Abandoned
- 2003-06-04 ZA ZA200501839A patent/ZA200501839B/xx unknown
- 2003-06-04 WO PCT/US2003/017682 patent/WO2004019857A2/en active Application Filing
- 2003-06-04 MX MXPA05002287A patent/MXPA05002287A/es unknown
- 2003-06-04 JP JP2004532575A patent/JP2006512901A/ja not_active Withdrawn
- 2003-06-04 KR KR1020057003483A patent/KR20050057047A/ko not_active Application Discontinuation
-
2005
- 2005-03-21 US US11/085,775 patent/US20050260634A1/en not_active Abandoned
-
2006
- 2006-09-29 US US11/537,516 patent/US20070117124A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MXPA05002287A (es) | 2005-08-18 |
WO2004019857A3 (en) | 2006-03-16 |
CA2496925A1 (en) | 2004-03-11 |
EP1575515A4 (en) | 2007-08-08 |
JP2006512901A (ja) | 2006-04-20 |
AU2003243398A1 (en) | 2004-03-19 |
WO2004019857A2 (en) | 2004-03-11 |
EP1575515A2 (en) | 2005-09-21 |
KR20050057047A (ko) | 2005-06-16 |
US20050260634A1 (en) | 2005-11-24 |
US20070117124A1 (en) | 2007-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1571968A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TUMORS | |
IL165950A0 (en) | Compositions and method for the diagnosis and treatment of tumor | |
EP1578996A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING TUMORS | |
EP1553912A4 (en) | COMPOSITIONS AND METHODS FOR TUMOR DIAGNOSIS AND TREATMENT | |
IL174047A0 (en) | Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer | |
EP1575571A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING A TUMOR | |
EP1551990A4 (en) | DIAGNOSIS AND TREATMENT OF CHEMOSTORED TUMORS | |
EP1576169A4 (en) | THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING THE SAME, AND METHODS OF USE THEREOF | |
AU2003294217A8 (en) | Human polypeptides encoded by polynucleotides and methods of their use | |
IL162201A0 (en) | New methods for diagnosis and treatment of tumours | |
EP1581652A4 (en) | IDENTIFICATION OF SEQUENCES PARTICULAR USEFUL IN THE DIAGNOSIS AND IDENTIFICATION OF THERAPEUTIC TARGETS FOR OSTEO ARTHRITIS | |
HK1079220A1 (en) | Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases cd83 | |
ZA200510282B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1487864A4 (en) | THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING THESE POLYPEPTIDES AND METHODS OF USE THEREOF | |
AU2003237792A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
ZA200501839B (en) | Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor | |
AU2003217956A8 (en) | Therapeutic polypeptides, nucleic acids encoding same and methods of use | |
EP1695078A4 (en) | METADHERINE POLYPEPTIDES, CODING NUCLEIC ACIDS AND METHOD OF USE | |
EP1401858A4 (en) | THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS COATING THEREOF AND METHOD OF USE | |
EP1432726A4 (en) | THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS CODED FOR THEM, AND METHOD OF USE | |
EP1549671A4 (en) | THERAPEUTIC POLYPEPTIDES, THESE CODING NUCLEIC CAUSE, AND USE PROCESS | |
EP1539985A4 (en) | THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING THESE POLYPEPTIDES, AND METHODS OF USE | |
EP1399537A4 (en) | THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING THEM, AND METHODS OF USE | |
AU2003245858A8 (en) | Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases | |
ZA200604365B (en) | Compositions and methods for the diagnosis and treatment of tumor |